Biomaterial-based therapeutic strategies for oral submucous fibrosis. [PDF]
Su Y +5 more
europepmc +1 more source
Anti-Fibrotic MicroRNA-Based Intervention in Oral Submucous Fibrosis: A Scoping Review. [PDF]
Shetty SS, Sharma M, Radhakrishnan R.
europepmc +1 more source
Fibrotic-Angiogenic Signaling Networks in Oral Submucous Fibrosis: Pathobiology and Therapeutic Targeting. [PDF]
Kamran S +4 more
europepmc +1 more source
Machine learning-assisted chemometric analysis of salivary ATR-FTIR spectra for the diagnosis of oral submucous fibrosis. [PDF]
Shree P +8 more
europepmc +1 more source
<i>AKT3</i> and α-SMA in oral submucous fibrosis and oral squamous cell carcinoma with concomitant oral submucous fibrosis as potential prognostic indicators. [PDF]
Behera S +5 more
europepmc +1 more source
CBCT evaluation of temporomandibular joint changes in patients with oral submucous fibrosis. [PDF]
Kumar S +5 more
europepmc +1 more source
A scoping review protocol mapping the anti-fibrotic and chemopreventive mechanisms of dietary polyphenols (curcumin, EGCG, resveratrol, quercetin) in oral submucous fibrosis, following PRISMA-ScR ...
Nguyễn Lêna
core
Silencing the mir-132/SIRT1 axis suppresses NLRP3 inflammasome activation and myofibroblast differentiation in oral submucous fibrosis. [PDF]
Chou MY +5 more
europepmc +1 more source
A systematic review and network meta-analysis of single nucleotide polymorphisms associated with oral submucous fibrosis risk. [PDF]
Huang C +7 more
europepmc +1 more source

